Quality of life in patients with pancreatic cancer

Journal of the Pancreas

Volumn 13, Issue 2, 2012, Pages 182-184

  Lee, Valerie ^a   Cheng, Haiying ^a   Li, Guangyuan ^a   Saif, Muhammad Wasif ^a  

^a Department of Medicine   (United States)

Author keywords

Palliative care; Pancreatic neoplasms; Quality of life

Indexed keywords

GEMCITABINE;

ARTICLE; BILE DUCT OBSTRUCTION; CACHEXIA; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER PAIN; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; DISEASE SEVERITY; FATIGUE; HUMAN; INTESTINE OBSTRUCTION; MALABSORPTION; MONOTHERAPY; MORBIDITY; PANCREAS CANCER; PROGNOSIS; QUALITY OF LIFE; SYMPOSIUM; THROMBOEMBOLISM; TREATMENT DURATION;

FEAR; HUMANS; PALLIATIVE CARE; PANCREATIC NEOPLASMS; QUALITY OF LIFE;

EID: 84863350416     PISSN: 15908577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. American Cancer Society. Cancer Facts & Figures 2012. Atlanta: American Cancer Society 2012.
2. Burris HA, Moore MJ, Andersen J et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 1997; 15: 2403-2413. [PMID 9196156]
3. Fazal S, Saif MW. Supportive and palliative care of pancreatic cancer. JOP 2007; 8: 240-253. [PMID 17356251]
4. Gupta D, Lis CG, Grutsch JF. The European organization for research and treatment of cancer quality of life questionnaire: implications for prognosis in pancreatic cancer. Int J Gastrointest Cancer 2006; 37: 65-73. [PMID 17827524]
5. Lis CG, Gupta D, Grutsch JF. Patient satisfaction with quality of life as a predictor of survival in pancreatic cancer. Int J Gastrointest Cancer 2006; 37: 35-44. [PMID 17290079]
6. Bernhard J, Dietrich D, Glimelius B et al. Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy. Br J Cancer 2010; 103: 1318-1324. [PMID 20877359]
7. Wang XS, Fogelman DR, Shi Q et al. Patient-reported symptoms from patients with advanced pancreatic cancer undergoing gemcitabine-based chemotherapy. J Clin Oncol 2012; 30: Suppl 4; abstr 370.
8. Kuwahara A, Mitsunaga S, Ohno I et al. Symptom change that predict disease control by systemic chemotherapy in patients with advanced pancreatic cancer. J Clin Oncol 2012; 30: suppl 4; abstr 195.
9. Romanus D, Kindler HL, Archer L et al. Does Health-Related Quality of Life Improve for Advanced Pancreatic Cancer Patients Who Respond to Gemcitabine? Analysis of a Randomized Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303). J Pain Symptom Manage 2012; 43: 205-217. [PMID 22104618]
10. Petzel MQB, Parker NH, Valentine AD et al. Fear of cancer recurrence and quality of life among survivors of pancreatic and periampullary neoplasms. J Clin Oncol 2012; 30: Suppl 4; Abstr 289.
11. Koch L, Jansen L, Brenner H, Arndt V. Fear of recurrence and disease progression in long-term (>/=5 years) cancer survivors-a systematic review of quantitative studies. Psychooncology 2012. [PMID 22232030]